Macrolide Pharmaceuticals Secures $22,000,000 Series A Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e974622e-dd68-47b8-ac7c-0803a23fd72f - Date
3/5/2015 - Company Name
Macrolide Pharmaceuticals - Mailing Address
3 Newton Executive Park Newton, MA 02462 USA - Company Description
Macrolide Pharmaceuticals, LLC. is a new anti-infective company founded to advance groundbreaking technology developed by Professor Andrew Myers of Harvard University. - Website
http://www.macrolidepharma.com - Transaction Type
Venture Equity - Transaction Amount
$22,000,000 - Transaction Round
Series A - Proceeds Purposes
Proceeds of the financing will enable Macrolide Pharmaceuticals to expand its proprietary drug discovery platform and accelerate the development of a pipeline of novel antibiotics. - M&A Terms
- Venture Investor
- Venture Investor
- Venture Investor
